Pfizer Vaccine Effective Against South African Variant

The video discusses a drugmaker's phase three clinical trial involving 12,000 participants, which showed high levels of protection against COVID-19, including the South African variant, six months after the second dose. The company plans to seek full FDA approval and has submitted trial data for peer review.

What new insight or understanding did you gain from this video?